Wellgenix

L-Argicor

Serving
2 Tablet(s)
Form
tablet
UPC
759051050303
DSLD
Caution-flaggedObjective label signals
Flagged excipients
1
0 avoid · 1 caution
FDA recalls
0
no recall history
CAERS reports
1
FDA consumer events
Certifications
0
none recorded
1 excipient carry authority-caution citations. · Every flag below links to the authority's published citation.

Supplement Facts

3 active ingredients
IngredientAmount% DV
Niacin
UNII · 2679MF687A
10 mg50%
Zinc
UNII · J41CSQ7QDS
50 mg333%
Proprietary Potency Blend
Proprietary Blend (Combination)
921 mg
Flagged excipients

1 flagged · authority citations

  • ◐ CAUTIONFD&C Blue #1
    color

    EU requires 'attention in children' warning per Commission Regulation 1333/2008 Annex III. Limited to specific food categories; capsule-shell use permitted with restrictions.

FDA CAERS · adverse event context
1
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Dicalcium Phosphate · Silica · Modified Cellulose Gum · Magnesium Stearate · Stearic Acid